Stocks News

LAST PRICE
162.5400
TODAY'S CHANGE (%)
Trending Down-0.7300 (-0.4471%)

Bid / Lots
160.0000/ 1
Ask / Lots
166.5000/ 8
Open / Previous Close
163.8200 / 163.2700
Day Range
Low 161.7000
High 165.5000
52 Week Range
Low 126.9681
High 225.2300
Volume
101,477
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Jul 23, 2024
- BeiGene Opens Flagship US Biologics Manufacturing Facility in New Jersey, from 11:59AM ET on Tuesday Jul 23, 2024 by MT Newswires
  11:59AM ET on Tuesday Jul 23, 2024 by MT Newswires
  Companies Mentioned: BGNE
  11:59 AM EDT, 07/23/2024 (MT Newswires) -- BeiGene (BGNE) said Tuesday it has opened its flagship biologics manufacturing facility and clinical research and development facility in Hopewell, New Jersey, located at the Princeton West Innovation Campu...
- BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World, from 7:00AM ET on Tuesday Jul 23, 2024 by Dow Jones
  7:00AM ET on Tuesday Jul 23, 2024 by Dow Jones
  Companies Mentioned: BGNE
  
  $800 million investment in New Jersey supports global growth and expansion with technologically advanced manufacturing capacity and clinical development capabilities for novel cancer medicines
Jul 18, 2024
- BeiGene Names Aaron Rosenberg CFO, from 7:19AM ET on Thursday Jul 18, 2024 by MT Newswires
  7:19AM ET on Thursday Jul 18, 2024 by MT Newswires
  Companies Mentioned: BGNE
  07:19 AM EDT, 07/18/2024 (MT Newswires) -- BeiGene (BGNE) said Thursday that it has named Aaron Rosenberg as its chief financial officer, effective July 22. Rosenberg was most recently the corporate treasurer at Merck (MRK), BeiGene said. He succeed...
- DJ BeiGene Names Rosenberg Finance Chief as Wang Departs, from 7:15AM ET on Thursday Jul 18, 2024 by Dow Jones
  7:15AM ET on Thursday Jul 18, 2024 by Dow Jones
  Companies Mentioned: BGNE
  
  By Colin Kellaher
  
  Oncology company BeiGene is replacing its top finance executive.
  
  BeiGene on Thursday said Aaron Rosenberg is joining the company as chief financial officer effective July 22, while Julia Wang, who has held the post since 2021, is leaving to pursue other opportunities.
- BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer, from 6:30AM ET on Thursday Jul 18, 2024 by Dow Jones
  6:30AM ET on Thursday Jul 18, 2024 by Dow Jones
  Companies Mentioned: BGNE
  SAN MATEO, Calif.--(BUSINESS WIRE)--July 18, 2024--
  BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22. Mr. Rosenberg will succeed Julia Wang, who is departing to pursue external opportunities and will stay with the Company through August to support the transition.

Yesterday
- HC Wainwright Adjusts Price Target on United Therapeutics to $400 From $300, Maintains Buy Rating, from 10:45AM ET on Thursday Jul 25, 2024 by MT Newswires
  10:45AM ET on Thursday Jul 25, 2024 by MT Newswires
  Companies Mentioned: UTHR
- DJ Neurocrine Price Target Maintained With a $155.00/Share by Cantor Fitzgerald, from 10:28AM ET on Thursday Jul 25, 2024 by Dow Jones
  10:28AM ET on Thursday Jul 25, 2024 by Dow Jones
  Companies Mentioned: NBIX
- DJ BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity, from 9:18AM ET on Thursday Jul 25, 2024 by Dow Jones
  9:18AM ET on Thursday Jul 25, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ United Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:37AM ET on Thursday Jul 25, 2024 by Dow Jones
  6:37AM ET on Thursday Jul 25, 2024 by Dow Jones
  Companies Mentioned: UTHR
- BioMarin Pharmaceutical Gets FDA Nod for Supplemental BLA to Slow Ambulation Loss in Tripeptidyl Peptidase 1 Deficiency, from 5:39AM ET on Thursday Jul 25, 2024 by MT Newswires
  5:39AM ET on Thursday Jul 25, 2024 by MT Newswires
  Companies Mentioned: BMRN
Jul 24, 2024
- U.S. Food and Drug Administration Approves BioMarin's BRINEURA(R) (cerliponase alfa) for Children Under 3 Years with CLN2 Disease, from 4:05PM ET on Wednesday Jul 24, 2024 by Dow Jones
  4:05PM ET on Wednesday Jul 24, 2024 by Dow Jones
  Companies Mentioned: BMRN
- Press Release: United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024, from 7:08AM ET on Wednesday Jul 24, 2024 by Dow Jones
  7:08AM ET on Wednesday Jul 24, 2024 by Dow Jones
  Companies Mentioned: UTHR
- United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024, from 7:00AM ET on Wednesday Jul 24, 2024 by Dow Jones
  7:00AM ET on Wednesday Jul 24, 2024 by Dow Jones
  Companies Mentioned: UTHR
Jul 23, 2024
- BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET, from 8:00AM ET on Tuesday Jul 23, 2024 by Dow Jones
  8:00AM ET on Tuesday Jul 23, 2024 by Dow Jones
  Companies Mentioned: BMRN
Jul 22, 2024
- DJ BioMarin Pharmaceutical Price Target Maintained With a $110.00/Share by Cantor Fitzgerald, from 11:32AM ET on Monday Jul 22, 2024 by Dow Jones
  11:32AM ET on Monday Jul 22, 2024 by Dow Jones
  Companies Mentioned: BMRN

Beigene Ltd
NASDAQ:BGNEUnited States

Search Criteria

Jul 23, 2024

BeiGene Opens Flagship US Biologics Manufacturing Facility in New Jersey, from 11:59AM ET on Tuesday Jul 23, 2024 by MT Newswires

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World, from 7:00AM ET on Tuesday Jul 23, 2024 by Dow Jones

Jul 18, 2024

BeiGene Names Aaron Rosenberg CFO, from 7:19AM ET on Thursday Jul 18, 2024 by MT Newswires

DJ BeiGene Names Rosenberg Finance Chief as Wang Departs, from 7:15AM ET on Thursday Jul 18, 2024 by Dow Jones

BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer, from 6:30AM ET on Thursday Jul 18, 2024 by Dow Jones

Peers Headlines

Yesterday

HC Wainwright Adjusts Price Target on United Therapeutics to $400 From $300, Maintains Buy Rating, from 10:45AM ET on Thursday Jul 25, 2024 by MT Newswires

DJ Neurocrine Price Target Maintained With a $155.00/Share by Cantor Fitzgerald, from 10:28AM ET on Thursday Jul 25, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity, from 9:18AM ET on Thursday Jul 25, 2024 by Dow Jones

DJ United Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:37AM ET on Thursday Jul 25, 2024 by Dow Jones

BioMarin Pharmaceutical Gets FDA Nod for Supplemental BLA to Slow Ambulation Loss in Tripeptidyl Peptidase 1 Deficiency, from 5:39AM ET on Thursday Jul 25, 2024 by MT Newswires

Jul 24, 2024

U.S. Food and Drug Administration Approves BioMarin's BRINEURA(R) (cerliponase alfa) for Children Under 3 Years with CLN2 Disease, from 4:05PM ET on Wednesday Jul 24, 2024 by Dow Jones

Press Release: United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024, from 7:08AM ET on Wednesday Jul 24, 2024 by Dow Jones

United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024, from 7:00AM ET on Wednesday Jul 24, 2024 by Dow Jones

Jul 23, 2024

BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET, from 8:00AM ET on Tuesday Jul 23, 2024 by Dow Jones

Jul 22, 2024

DJ BioMarin Pharmaceutical Price Target Maintained With a $110.00/Share by Cantor Fitzgerald, from 11:32AM ET on Monday Jul 22, 2024 by Dow Jones